Clinical Trial Update: Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children Outpatients

View source ↗

Summary

A completed non-interventional study assessing Pulmicort Respules (budesonide) for cough variant asthma in pediatric outpatients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough-variant Asthma

Drugs mentioned

• Pulmicort Respules (budesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Cough Variant Asthma | Status: COMPLETED